The Buoniconti Fund, Permobil partner for mobility research awareness

Thursday, May 1, 2014

Nick and Marc Buoniconti, in conjunction with the Buoniconti Fund to Cure Paralysis, the fundraising arm of the Miami Project to Cure Paralysis, have announced a partnership with Permobil, a wheelchair provider, to jointly promote mobility and paralysis research awareness.

“Having used Permobil exclusively since my injury, I am proud to endorse Permobil products because their durability and reliability are truly extraordinary. The partnership between The Buoniconti Fund and Permobil can only enhance awareness of our joint mission of helping to move people who suffer debilitation accidents and conditions,” said Marc Buoniconti.

The partnership will include promoting the need for R&D into paralysis and other devastating neurological disorders. The agreement also will educate people about reliable mobility devices and allow for The Buoniconti Fund to periodically donate Permobil wheelchairs to needy individuals.

The Miami Project’s Christine E. Lynn Clinical Trials Initiative is designed to fast track successful laboratory studies to human studies. The company’s FDA-approved Schwann cell transplantation trial, the only one of its kind in the world, is changing the spinal cord injury field and sets an important foundation for future Miami Project cell replacement therapies.

Miami Project researchers are conducting or participating in more than 10 clinical trials for spinal cord and brain injuries, and have more than a dozen clinical research studies underway.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!